High: Low:
| Spread | 0.83 | Spread (%) | 0.50% |
|---|---|---|---|
| Overnight funding - Buy | -0.05424% | Overnight funding - Sell | -0.03348% |
| Initial margin | 20.00% | Maintenance margin | 10.00% |
| Leverage | 1:5 | Expires daily | No |
| Name | Sell | Sell button / Change | Buy | Change Change | Change Change | Change Change | |||
|---|---|---|---|---|---|---|---|---|---|
| {{item.Name}} | {{item.SellPrice}} | Sell | Buy | {{item.ChangePercentText}} | Trade | ||||
Yesterday, Moderna announced a partnership in the development of a new cancer vaccine, while Pfizer got FDA approval to provide its booster shot to children, giving the share prices of both a bump.
Read More
Pfizer's preliminary analysis of its COVID-19 antiviral pill provided very high success rates. Pfizer's CEO has spoken of his company's pill as a "game-changer." Is he right? How might this pill affect the stock prices of Pfizer and its competitors, as well as the broader market?
Read More
The Pfizer COVID-19 vaccine could soon receive FDA approval for use in children between the ages of 12 and 15. The shot may be authorized by early next week in hopes that widespread adoption will ease the start of the school year in September.
Read More
Hi! You've reached our website for customers based outside of the United States.
Make the move to Plus500US in order to start your Futures trading journey!
